Drug Shortage Report for JAMP-NYSTATIN ORAL SUSPENSION USP
Report ID | 211795 |
Drug Identification Number | 02433443 |
Brand name | JAMP-NYSTATIN ORAL SUSPENSION USP |
Common or Proper name | Nystatin Oral Suspension USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | NYSTATIN |
Strength(s) | 100000UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A07AA |
ATC description | INTESTINALANTIINFECTIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-11-27 |
Estimated end date | 2024-05-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-11 |
Company comments | 500 mL available under allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-03-11 | French | Compare |
v7 | 2024-03-11 | English | Compare |
v6 | 2024-03-04 | French | Compare |
v5 | 2024-03-04 | English | Compare |
v4 | 2024-02-19 | French | Compare |
v3 | 2024-02-19 | English | Compare |
v2 | 2023-11-28 | French | Compare |
v1 | 2023-11-28 | English | Compare |
Showing 1 to 8 of 8